Skip to main content
Premium Trial:

Request an Annual Quote

Bioké Inks Distribution Deal for Advanced Cell Diagnostics Products in Benelux Region

NEW YORK (GenomeWeb News) – Bioké and Advanced Cell Diagnostics today announced a distribution deal covering the Benelux region.

Under the terms of the deal, which took effect on May 1, Bioké will promote, sell, and provide technical and customer support for ACD products in Belgium, Luxembourg, and the Netherlands. Financial and other terms were not disclosed.

ACD, based in Hayward, Calif., is a molecular pathology company. Its products and services are based on its RNAscope technology, an in situ hybridization platform for detecting and quantifying RNA biomarkers at single-molecule sensitivity. It offers single and multiplex readouts in chromogenic and fluorescent formats.

Bioké, headquartered in Leiden, the Netherlands, sells life science and diagnostics products.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.